Iris Grossman, PhD in

Iris Grossman, PhD

Login to view DISC.
Chief Therapeutics Officer at Eleven Therapeutics
📍 Newton, Massachusetts, United States

Iris Grossman is the Chief Therapeutics Officer at Eleven Therapeutics, bringing over 20 years of experience from both Big Pharma and biotech startups. A graduate of Technion, she is a leader in personalized medicine, RNA therapeutics, and AI in drug discovery, with a focus on neurological and metabolic diseases.

Iris is passionate about mentorship and is actively involved with Executive Women In Bio (eWIB), where she chairs several initiatives. Her focus is on empowering other professionals and paying forward her knowledge within the life sciences community.

Interesting fact: Iris was named one of the "Top 40 under 40" by Globes, a prominent Israeli business publication, for her significant contributions to the industry.

Read the full overview →
Experience
17 Years
Current Role
Chief Therapeutics Officer
Job Level
Leadership
Location
Newton, Massachusetts, United States
Personality Overview

How Iris shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Iris cares about

RNA Therapeutics
As CTxO of Eleven Therapeutics, her work is centered on developing a pipeline of novel RNA-based therapeutics, a core focus of her current professional endeavors.
Personalized Medicine
Described as a pioneer in the field, she leverages human genetics, biomarkers, and patient data to create targeted and effective therapeutic strategies.
+5 more topics Login to view topics
Career

Work history

5-2022
Chief Therapeutics Officer
Eleven Therapeutics
9-2021 - 7-2022
Chief Strategy Officer (CSO)
Eleven Therapeutics
4-2020 - 8-2021
Founding Advisor, SAB member
Eleven Therapeutics
7-2022
Strategic Founder Advisor
Modulight.bio
11-2007
Co-founder and President
GROSS Advantage (formerly IsraGene)
In the press

Media appearances

Eleven Therapeutics Appoints Prominent Biopharma Leader Dr. Iris Grossman as Chief Strategic Officer. Featured in Eleven Therapeutics
See now
Eleven Therapeutics Appoints Prominent Biopharma Leader Dr. Iris Grossman. Featured in Medium
+1 more appearances Login to view media
Education
1998 - 2004
B.Sc. & Direct PhD
Technion - Israel Institute of Technology
9-2023 - 12-2023
Boardroom Ready
The George Washington University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Laxmi Narayan Naik
Laxmi Narayan Naik
Managing Director
Hexaware Technologies Asia Pacific Pte Ltd.
S.
sasteghar .com
owner at sasteghar.com
 Chirag Thakkar
Chirag Thakkar
Associate Director – Enterprise Technology Product / SaaS Sector
Native
 Marcel Gritter
Marcel Gritter
Belastingadviseur | Partner Omnyacc Accountants & Adviseurs
Omnyacc
Unlock the full playbookSee exactly how to sell to Iris. Free, 10 seconds.